Wayne Foster Biography and Net Worth

Wayne has more than 20 years of financial management experience in the biopharmaceutical industry. Prior to joining Atea, Wayne served as Vice President of Finance at Mersana Therapeutics, Inc. for seven years where he was a key member of the team that led the company’s transition from a preclinical, privately held company to a clinical stage, publicly traded company. Prior to Mersana, Wayne served for nine years as Senior Director of Finance at Tolerx, where he was responsible for a wide variety of finance functions during a period of significant growth for the company. Earlier in his career, Wayne spent nine years as a Senior Manager at Arthur Andersen, where he specialized in emerging life science and technology companies.

Wayne holds a BBA in Accounting from the University of Massachusetts Amherst.

What is Wayne Foster's net worth?: The estimated net worth of Wayne Foster is at least $64.45 thousand as of February 1st, 2024. Foster owns 20,857 shares of Atea Pharmaceuticals stock worth more than $64,448 as of December 4th. This net worth evaluation does not reflect any other investments that Foster may own. Additionally, Foster receives an annual salary of $580,460.00 as CAO at Atea Pharmaceuticals. Learn More about Wayne Foster's net worth.
How old is Wayne Foster?: Foster is currently 55 years old. There are 5 older executives and no younger executives at Atea Pharmaceuticals. The oldest executive at Atea Pharmaceuticals is Dr. Jean-Pierre Sommadossi Ph.D., Founder, Chairman, CEO & President, who is 68 years old. Learn More on Wayne Foster's age.
What is Wayne Foster's salary?: As the CAO of Atea Pharmaceuticals, Inc., Foster earns $580,460.00 per year. There are 5 executives that earn more than Foster. The highest earning executive at Atea Pharmaceuticals is Dr. Jean-Pierre Sommadossi Ph.D., Founder, Chairman, CEO & President, who commands a salary of $1,040,000.00 per year. Learn More on Wayne Foster's salary.
How do I contact Wayne Foster?: The corporate mailing address for Foster and other Atea Pharmaceuticals executives is , , . Atea Pharmaceuticals can also be reached via phone at 857-284-8891 and via email at [email protected]. Learn More on Wayne Foster's contact information.
Has Wayne Foster been buying or selling shares of Atea Pharmaceuticals?: Wayne Foster has not been actively trading shares of Atea Pharmaceuticals during the past quarter. Most recently, Wayne Foster sold 12,477 shares of the business's stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $3.84, for a transaction totalling $47,911.68. Following the completion of the sale, the chief accounting officer now directly owns 20,857 shares of the company's stock, valued at $80,090.88. Learn More on Wayne Foster's trading history.
Who are Atea Pharmaceuticals' active insiders?: Atea Pharmaceuticals' insider roster includes Franklin Berger (Director), Andrea Corcoran (Insider), Wayne Foster (CAO), Polly Murphy (Director), Bruce Polsky (Director), and Jean-Pierre Sommadossi (CEO). Learn More on Atea Pharmaceuticals' active insiders.
Are insiders buying or selling shares of Atea Pharmaceuticals?: During the last twelve months, insiders at the sold shares 1 times. They sold a total of 359,606 shares worth more than $1,024,877.10. The most recent insider tranaction occured on December, 10th when Director Franklin M Berger sold 359,606 shares worth more than $1,024,877.10. Insiders at Atea Pharmaceuticals own 18.1% of the company. Learn More about insider trades at Atea Pharmaceuticals.
Information on this page was last updated on 12/10/2024.

Wayne Foster Insider Trading History at Atea Pharmaceuticals

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
2/1/2024	Sell	12,477	$3.84	$47,911.68	20,857

Wayne Foster Buying and Selling Activity at Atea Pharmaceuticals

Atea Pharmaceuticals Company Overview

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes antiviral therapeutics for patients with viral infections. Its lead product candidate is AT-527, an oral antiviral candidate that is in Phase 3 SUNRISE-3 clinical trial for the treatment of patients with COVID-19. The company also develops bemnifosbuvir in combination with ruzasvir, which is in Phase 2 clinical trial, for the treatment of hepatitis C virus (HCV); and a protease inhibitor for the treatment of COVID-19. It has a license agreement with MSD International GmbH for the development, manufacture, and commercialization of Ruzasvir, an NS5A inhibitor, for the treatment of HCV. Atea Pharmaceuticals, Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $3.09

$3.03

$3.13

50 Day Range

MA: $3.12

$2.82

$3.50

2 Week Range

Now: $3.09

$2.45

$4.02

Volume

497,950 shs

Average Volume

411,257 shs

Market Capitalization

$241.42 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.16

Wayne Foster Biography and Net Worth

What is Wayne Foster's net worth?

How old is Wayne Foster?

What is Wayne Foster's salary?

How do I contact Wayne Foster?

Has Wayne Foster been buying or selling shares of Atea Pharmaceuticals?

Who are Atea Pharmaceuticals' active insiders?

Are insiders buying or selling shares of Atea Pharmaceuticals?